Targeting Catechol-O-Methyl Transferase (COMT) Inhibitors for Schizophrenia:An Approach to Target Validation and Rational Drug Design

By  

Letters in Drug Design & Discovery, Vol. 8, Iss. 3, 2011-03 ,pp. : 246-252

Bentham Science Publishers

Access to resources Recommend Favorite

Catechol-O-Methyl Transferase Modulates Cognition in Late Life: Evidence and Implications for Cognitive Enhancement

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 3, 2012-05 ,pp. : 195-208

Bentham Science Publishers

Access to resources Recommend Favorite

Catechol- O -Methyl Transferase (COMT) Inhibitors in Patients with Parkinson's Disease: Is COMT Genotype a Useful Indicator of Clinical Efficacy?

By Rinne J.O.  

American Journal of PharmacoGenomics, Vol. 3, Iss. 1, 2003-01 ,pp. : 11-15

Adis International

Access to resources Recommend Favorite

Association of functional catechol O-methyl transferase (COMT) Val108Met polymorphism with smoking severity and age of smoking initiation in Chinese male smokers

By Guo Song   Chen Da   Zhou Dong   Sun Hong   Wu Gui   Haile Colin   Kosten Therese   Kosten Thomas   Zhang Xiang  

Psychopharmacology, Vol. 190, Iss. 4, 2007-03 ,pp. : 449-456

Springer Publishing Company

Access to resources Recommend Favorite

The Cholinergic System: An Emerging Drug Target for Schizophrenia

By  

Current Pharmaceutical Design, Vol. 22, Iss. 14, 2016-04 ,pp. : 2124-2133

Bentham Science Publishers

Access to resources Recommend Favorite